The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up

Autor: Harper, Diane M., Nieminen, Pekka, Donders, Gilbert, Einstein, Mark H., Garcia, Francisco, Huh, Warner K., Stoler, Mark H., Glavini, Katerina, Attley, Gemma, Limacher, Jean-Marc, Bastien, Berangere, Calleja, Elizabeth
Zdroj: In Gynecologic Oncology June 2019 153(3):521-529
Databáze: ScienceDirect